Abstract: The present invention provides a base composition that allows for the formulation of non-irritating cosmetic and/or dermatological compositions. The base composition includes one or more of electrolyte, buffer, mild preservative, lubricant, or any combinations thereof. It is preferred that one or more of the above components are eye-safe and/or eye-compatible. The present invention also provides photoprotective cosmetic and/or dermatological compositions that include the base composition and one or more sunscreen active components and are non-irritating to mammalian eyes.

Abstract: The present invention is directed to an emulsion base for formulating cosmetic and dermatological compositions. The emulsion base has particular surfactant and/or emulsifier ratios such that a wide range of compositions with varying forms and additional components can be formulated without changing the ratio or amount of the primary and/or co-surfactant/emulsifier in the emulsion base or the amount of the emulsion base in the final composition. The emulsion base can be used in a system of formulating cosmetic and dermatological compositions.

Abstract: The present invention provides a photo-protective composition that has a synergistic combination of at least one sunscreen agent and at least one carotenoid, which results in a composition with an increased SPF compared to a composition without the synergistic combination. Preferably, the composition also has at least one of the following additional components: emulsifier, emollient, skin-feel additive, moisturizing agent, film former/waterproofing agent, pH adjuster/chelating agent, preservative, or any combinations thereof.

Abstract: A sunless tanning composition having dihydroacetone and an amphoglycinate (amphoacetate) in an amount effective for sunless tanning is provided. Also provided is a method of sunless tanning having the step of topically applying to the skin an effective amount of a sunless tanning composition having dihydroacetone and an amphoglycinate.

Abstract: The present invention provides a base composition that allows for the formulation of non-irritating cosmetic and/or dermatological compositions. The base composition includes one or more of electrolyte, buffer, mild preservative, lubricant, or any combinations thereof. It is preferred that one or more of the above components are eye-safe and/or eye-compatible. The present invention also provides photoprotective cosmetic and/or dermatological compositions that include the base composition and one or more sunscreen active components and are non-irritating to mammalian eyes.

Abstract: The present invention provides a base composition that allows for the formulation of non-irritating cosmetic and/or dermatological compositions. The base composition includes one or more of electrolyte, buffer, mild preservative, lubricant, or any combinations thereof. It is preferred that one or more of the above components are eye-safe and/or eye-compatible. The present invention also provides photoprotective cosmetic and/or dermatological compositions that include the base composition and one or more sunscreen active components and are non-irritating to mammalian eyes.

Abstract: A sunless tanning composition having dihydroacetone and an amphoglycinate (amphoacetate) in an amount effective for sunless tanning is provided. Also provided is a method of sunless tanning having the step of topically applying to the skin an effective amount of a sunless tanning composition having dihydroacetone and an amphoglycinate.

Abstract: The present invention is directed to a cosmetic composition that has an amount of at least two rheology-modifying agents such that the viscosity of the composition remains stable over a broad temperature range. The compositions of the present invention may also include at least one of the following additional components: sunscreen agent, SPF booster, secondary emulsifier, emollient, moisturizer, humectant, film former/waterproofing agent, bio-active (functional) ingredient, pH adjuster/chelating agent, preservative, fragrance, effect pigment, color additive, or any combinations thereof.

Abstract: An in vitro method for the prediction of in vivo UVA protection by a composition with sunscreen properties. The method includes the steps of: determining in vivo SPF; determining in vitro SPF based on the sunscreen's absorbance spectrum in the UV region; normalizing the absorbence spectrum based on integration area of UVA1; and calculating the PFA-PPD in vitro.

Abstract: There is provided a composition comprising one or more photoactive compounds and one or more optimization agents. Surprisingly, the composition requires a small amount of optimization agent to efficiently optimize the polarity, critical wavelength, SPF, PFA, Star Rating, photostability, or any combinations thereof, of the composition. Subsequently, an efficient sunscreen composition is achieved.

Abstract: An in vitro method for the prediction of in vivo UVA protection by a composition with sunscreen properties.

Abstract: The present invention is directed to a cosmetic composition that has an amount of at least two rheology-modifying agents such that the viscosity of the composition remains stable over a broad temperature range. The compositions of the present invention may also include at least one of the following additional components: sunscreen agent, SPF booster, secondary emulsifier, emollient, moisturizer, humectant, film former/waterproofing agent, bio-active (functional) ingredient, pH adjuster/chelating agent, preservative, fragrance, effect pigment, color additive, or any combinations thereof.

Abstract: An oil-in-water-in-silicone fluid (o/w/s) emulsion composition comprising (a) a silicone fluid continuous phase, (b) an aqueous discontinuous phase comprising an oil-in-water (o/w) emulsion, and (c) an effective dispersing amount of dimethicone copolyol for dispersing (b) in (a).

Abstract: Disclosed are medicated cleansing pads comprising: (a) from about 50% to about 75% of a nonwoven fabric material; (b) from about 20% to about 75% (on a dry solids basis) of a water soluble polymeric resin of the formula:(A.sub.x).sbsb.m (B.sub.y).sbsb.nwherein A is one or more monomers selected from styrene or styrene derivatives and B is one or more monomers selected from butadiene or butadiene derivatives, x is the number of different A monomer components present in the copolymer chain, with x being an integer of 1 or more and y is the number of B monomer components present in the copolymer chain, with y being an integer of 0 or more and m:n is the weight ratio of A monomer components to B monomer components, and is from about 10:1 to about 1:5, preferably from about 5:1 to about 1:2, and (c) from about 0.1% to about 50% of salicylic acid active composition.

Abstract: Disclosed are medicated cleansing pads comprising:(a) from about 50% to about 75% of two or more layers of nonwoven fabric materials;(b) from about 20% to about 75% (on a dry solids basis) of a water soluble polymeric resin of the formula: ##STR1## wherein A is one or more monomers selected from styrene or styrene derivatives and B is one or more monomers selected from butadiene or butadiene derivatives, x is the number of different A monomer components present in the copolymer chain, with x being an integer of 1 or more and y is the number of B monomer components present in the copolymer chain, with y being an integer of 0 or more and m:n is the weight ratio of A monomer components to B monomer components, and is from about 10:1 to about 1:5; and(c) from about 0.1% to about 50.0% of a salicylic acid active composition.This invention also encompasses a method of treating acne in humans and lower animals comprising topically applying to the affected area the medicated pads of the present invention.

Abstract: A method and composition for treating human skin, having applicabiity to oily skin and acne in order to improve the condition thereof by reducing the spreadability of sebum on the skin surface, the invention involving the application to human skin so characterized of a composition comprising, as an active component to reduce the spreadability of sebum, an effective amount of a straight chain dimethyl silicone polymer having a molecular weight of about 50,000 or more and a viscosity of about 10,000 centistokes or more.